吸引刮除术治疗腋臭的前瞻性队列研究
本研究为前瞻性队列研究,比较吸引刮除术(SCS)与小切口直视修剪术(SIDVTS)治疗中重度腋臭的疗效与安全性,纳入196例Park-Shin 2或3级患者。倾向评分匹配后两组治愈率无显著差异,但SCS并发症更少、瘢痕评分更优且愈合更快。
要点
- SCS治愈率非劣于SIDVTS,匹配后分别为89.7%与86.8%(P=0.791)。
- SCS并发症显著更少:皮瓣坏死、色素沉着、感染和血肿均低于SIDVTS。
- BMI≥28 kg/m²、年龄>31岁、空腹血糖>6.0 mmol/L和手术面积>17 cm²为并发症独立危险因素。
核心结论
- SCS治疗中重度腋臭的治愈率非劣于SIDVTS,且并发症更少、瘢痕更轻、恢复更快,可作为更安全的替代术式。
研究设计与样本
- 前瞻性队列研究,纳入196例Park-Shin 2或3级腋臭患者,SCS组96例,SIDVTS组100例,采用倾向评分匹配平衡基线混杂因素。
主要发现
- 匹配前治愈率SCS 89.6% vs SIDVTS 92.0%(P>0.05),匹配后89.7% vs 86.8%(P=0.791)。
- SCS组皮瓣坏死10.3% vs 27.9%(P=0.015),长期色素沉着5.9% vs 16.2%(P=0.045),感染2.9% vs 11.8%(P=0.049),血肿1.5% vs 10.3%(P=0.029)。
- 复发率两组相似(8.8% vs 7.4%,P=0.753);SCS瘢痕评分更优(P<0.05),愈合时间更短(8.03±1.30 vs 11.57±1.75天,P<0.05)。
- 多因素分析显示BMI≥28 kg/m²、年龄>31岁、空腹血糖>6.0 mmol/L和手术面积>17 cm²为两组并发症独立危险因素。
关键数值与推荐
- Park-Shin分级2或3级为中重度腋臭纳入标准。
- SCS治愈率非劣于SIDVTS,匹配后分别为89.7%和86.8%(P=0.791)。
- SCS并发症显著低于SIDVTS:皮瓣坏死10.3% vs 27.9%(P=0.015),色素沉着5.9% vs 16.2%(P=0.045),感染2.9% vs 11.8%(P=0.049),血肿1.5% vs 10.3%(P=0.029)。
- SCS愈合时间8.03±1.30天,SIDVTS 11.57±1.75天(P<0.05)。
- 并发症独立危险因素:BMI≥28 kg/m²、年龄>31岁、空腹血糖>6.0 mmol/L、手术面积>17 cm²。
临床怎么用
- 对中重度腋臭患者可优先考虑SCS,因其治愈率与SIDVTS相当且并发症更少、恢复更快。
- 术前评估BMI、年龄、空腹血糖和手术面积,对高风险患者加强并发症预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Axillary bromhidrosis leads to substantial psychosocial burden. This study compares the efficacy and safety of suction curettage surgery (SCS) versus small-incision direct-vision trimming surgery (SIDVTS) for moderate to severe cases. METHODS: In this prospective cohort study, 196 patients with Park-Shin grade 2 or 3 disease underwent SCS ( n = 96) or SIDVTS ( n = 100). Primary outcomes included 6-month cure rates and postoperative complications. Secondary outcomes encompassed healing time and Patient and Observer Scar Assessment Scale scores. Propensity score matching (PSM) balanced baseline confounders; multivariable analysis identified risk factors. RESULTS: Pre-PSM cure rates were comparable (SCS 89.6% versus SIDVTS 92.0%; P > 0.05). Post-PSM analysis confirmed no significant difference (89.7% versus 86.8%; P = 0.791). SCS demonstrated significantly fewer complications, including cutaneous necrosis (10.3% versus 27.9%; P = 0.015), long-term pigmentation (5.9% versus 16.2%; P = 0.045), infection (2.9% versus 11.8%; P = 0.049), and hematoma (1.5% versus 10.3%; P = 0.029). Recrudesce rates were similar (8.8% versus 7.4%; P = 0.753). SCS yielded superior scar outcomes ( P < 0.05) and faster healing (8.03 ± 1.30 versus 11.57 ± 1.75 days; P < 0.05). Multivariable analysis revealed body mass index of 28 kg/m 2 or higher, age older than 31 years, fasting glucose level greater than 6.0 mmol/L, and surgical area greater than 17 cm 2 as independent risk factors for complications in both groups. CONCLUSIONS: SCS achieved noninferior cure rates to SIDVTS with fewer complications, reduced scarring, and quicker recovery. Elevated body mass index, age, glucose level, or surgical area increased complication risks. These findings support SCS as a safer alternative for axillary bromhidrosis.
引用
- Wang Y, Chen M, Cai Z, et al. Effectiveness and Safety of Suction Curettage Surgery for Axillary Bromhidrosis: A Prospective Cohort Study. Plast Reconstr Surg. 2025. PMID: 41343767. doi:10.1097/PRS.0000000000012645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。